Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update evaluating three doses of SCV 07 to attenuate oral mucositis in patients with head and neck cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• SCV-07 (SCV-07)

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: Oral Mucositis | Phase 2 | Status: UNKNOWN